Table 4

Incidence rates of immune-mediated diarrhea and colitis in IBD and control cohorts

GroupsTotal NNumber of events at 6 months (rate %)Number of events at 1 year (rate %)
ICI diarrheaICI colitisimDCICI diarrheaICI colitisimDC
All patients1806 (3.3%)12 (6.7%)18 (10%)7 (3.9%)14 (7.8%)21 (11.7%)
 Control1503 (2%)4 (2.7%)7 (4.7%)4 (2.7%)6 (4%)10 (6.7%)
 IBD303 (10%)8 (26.7%)11 (36.7%)3 (10%)8 (26.7%)11 (36.7%)
  • Event, ICI colitis or ICI diarrhea; IBD, inflammatory bowel disease; ICI, immune checkpoint inhibitor; imDC, immune-mediated diarrhea and colitis; N, total sample size.